8-K: BioLargo Announces Second Consecutive Year of Doubled Annual Revenues Driven by Pooph Sales

BioLargo reports its annual revenues more than doubled for the second consecutive year, primarily driven by the success of its Pooph pet odor control product line.

Summary

• BioLargo, Inc. announced that its annual revenues for the year ended December 31, 2023, more than doubled compared to 2022.
• This marks the second consecutive year that the company's revenues have doubled.
• The revenue increase was primarily due to sales of the Pooph pet odor control product line.
• BioLargo serves as a technology partner and supplier to Pooph, Inc., which manages the marketing and distribution of the products.
• The company expects to earn its first revenues from its proprietary PFAS treatment technology in 2024.
• This is due to securing a key municipal drinking water project.
• BioLargo is still working to conclude its audit of its 2023 financial statements and intends to file its annual report with the SEC at the end of March.
• The revenue estimates for 2023 are preliminary and subject to change pending review and audit.

Sentiment

Score: 8

Explanation: The document conveys a very positive sentiment due to the significant revenue growth and promising outlook for new technologies. However, the preliminary nature of the revenue figures and the inherent risks in the business temper the sentiment slightly.

Positives

• The company has achieved significant revenue growth, doubling its annual revenues for the second consecutive year.
• The success of the Pooph product line validates BioLargo's business model.
• The company is expanding into new markets with its PFAS treatment technology.
• The company has secured a key municipal drinking water project.

Negatives

• The 2023 revenue figures are preliminary and subject to change after the audit.
• The company is dependent on the performance of distributors of its products.

Risks

• The company's business is subject to regional economic conditions.
• The company operates in highly competitive markets with rapid technological change.
• The company must manage frequent introductions and transitions of products and services.
• The company is dependent on the performance of distributors of its products.
• Actual results may differ materially from forward-looking statements.

Future Outlook

BioLargo expects continued growth in Pooph sales in 2024 and anticipates earning first revenues from its PFAS treatment technology this year. The company also sees encouraging market response to its other technologies.

Management Comments

• The success of Pooph validates our business model of inventing a best-in-class technology-based product, proving it up through world-class R&D, and partnering to maximize commercial reach.
• The team at Pooph informs us that they expect to continue growing sales in 2024 and by doing so, they will continue to increase the value of its brand.
• The response from the marketplace to our PFAS removal and water treatment related technologies as well as our long duration battery storage solution is highly encouraging for 2024 and beyond.

Industry Context

The announcement highlights BioLargo's success in the cleantech and environmental solutions sector, particularly in the pet product market with Pooph. The company's expansion into PFAS treatment aligns with growing concerns about water contamination and the need for effective remediation technologies.

Comparison to Industry Standards

• While specific revenue figures are not provided, doubling revenue for two consecutive years is a significant achievement, suggesting strong market traction for BioLargo's products.
• The success of Pooph is comparable to other successful consumer product launches in the pet care industry, such as Chewy's growth in online pet supplies.
• The move into PFAS treatment puts BioLargo in competition with companies like Evoqua Water Technologies and Xylem, which are also developing solutions for water contamination.
• The company's approach of partnering for commercial reach is similar to other technology companies that leverage distribution networks to scale their products.

Stakeholder Impact

• Shareholders will likely view the revenue growth positively.
• Employees may benefit from the company's success and expansion.
• Customers of Pooph will continue to have access to the product.
• Potential customers of the PFAS treatment technology may benefit from the new solutions.
• Suppliers to BioLargo and Pooph will likely see increased demand.

Next Steps

• The company will conclude its audit of the 2023 financial statements.
• The company intends to file its annual report with the SEC at the end of March.
• The company will continue to pursue growth in Pooph sales.
• The company will focus on securing more projects for its PFAS treatment technology.

Key Dates

Keywords

BioLargo, Pooph, revenue, PFAS, water treatment, odor control, cleantech, environmental technology, pet products